Clinical Practice, Ethics & Communication in Genetics

Short version. This page is the pillar for three connected subject areas in genetics teaching. Clinical genetic skills covers the structured family-history interview and the construction of a three-generation pedigree to a community-agreed notation. Diagnostics and counselling covers molecular-diagnostic test choice, variant-classification frameworks, the result-disclosure conversation, and the counselling models the field has developed. Ethics, legal, and social issues covers consent, privacy, data protection, the duty-to-warn debate, screening policy, equity in genomics, and the regulation of direct-to-consumer testing. Each subtopic has its own page; this is the index.

Why the field is taught as three connected areas

Clinical-genetic practice unusually intertwines technical skill, communication craft, and policy-level ethics. A clinical geneticist or genetic counsellor in training must learn to construct a pedigree that another reader can interpret unambiguously; must follow the trail from family history through laboratory test selection to a variant report classified using community criteria; must be comfortable with the disclosure conversation and the psychosocial dimensions of carrier and predictive testing; and must understand the regulatory, data-protection, and equity constraints that shape what can be offered, to whom, and on what terms. Competency frameworks from the National Society of Genetic Counselors (NSGC) in the US, the European Society of Human Genetics (ESHG), and equivalent professional bodies elsewhere recognise this breadth and structure curricula accordingly.

The three subtopic pages on this site treat each strand at the depth of a teaching survey. They are aimed at students of medicine, genetic counselling, nursing, and allied health, and at the educators who design or teach those modules. They cite the field-defining literature inline and link to authoritative sources and to relevant Evagene pages on pedigree drawing where useful.

Where "genetic counselling" came from

The term genetic counseling was introduced by Sheldon Reed in 1947 (with the spelling reflecting the American convention) and elaborated in his subsequent textbook in 1955. Reed's framing was deliberate: he wanted a phrase distinct from eugenics, with which the term genetic hygiene was associated, and which the post-war profession was anxious to dissociate itself from. Reed described counselling as the explanation of genetic facts in a way that supported the family's own decisions, framed by the geneticist's empathy for and respect for the autonomy of the people consulting them.

Joan Sheldon's 1949 work in the same period, and the establishment of human-genetics clinics at Johns Hopkins, the University of Michigan, and elsewhere in the 1940s and 1950s, set the template: a medically informed conversation that conveys risk information to families considering reproductive or testing decisions. The professionalisation of the field followed in the 1970s. The National Society of Genetic Counselors (NSGC) was founded in 1979, the first North American Master's-level training programme had opened at Sarah Lawrence College in 1969, and in 1993 the American Board of Genetic Counseling was established to certify graduates of those programmes.

The contemporary definition is the consensus statement by Robert Resta and colleagues, Resta et al. 2006 (J Genet Couns 15:77): "Genetic counseling is the process of helping people understand and adapt to the medical, psychological and familial implications of genetic contributions to disease." That definition is now standard in textbooks, accreditation documents, and international training frameworks; its three components — understanding, adaptation, and the family dimension — map to the three subtopic pages on this site.

Subtopic 1: clinical genetic skills

The introductory clinical skill in genetics is the structured family-history interview, in which a clinician asks systematic questions about three or more generations of biological relatives and records the result as a pedigree drawn to community-agreed notation. The current notation reference is the 2022 update from Bennett and colleagues (J Genet Couns 31:1238), itself the third revision of an NSGC standard first published in Bennett et al. 1995 (J Genet Couns 4:267) and updated in Bennett et al. 2008 (J Genet Couns 17:424). The 2022 update introduced more inclusive conventions for sex and gender alongside the long-established symbol set.

Beyond the symbol set, the literature on the genetic family-history interview covers the order in which the questions are asked, the role of ethnic and geographic background in shaping which conditions are discussed (Ashkenazi Jewish, Mediterranean, South Asian, Sub-Saharan African ancestry each carry distinctive carrier frequencies for specific conditions), and the features described in publications such as NICE CG164 and NG101 as warranting further work-up — multiple primary cancers in one individual, bilateral disease, early-onset disease, and clusters of related cancers in a family. The teaching subtopic page goes into detail on each. See clinical genetic skills.

Subtopic 2: diagnostics and counselling

Once a family-history pattern raises a hypothesis, the diagnostic pathway covers test choice (Sanger sequencing for a single variant; multi-gene panels; clinical exome and genome; chromosomal microarray; karyotype with FISH); pre-test counselling and consent; the variant-classification framework from Richards et al. 2015 (Genet Med 17:405) jointly issued by the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP); the management of secondary findings on the ACMG SF v3.3 list (Miller et al. 2025, Genet Med 27:101391, adding ABCD1, CYP27A1, and PLN; superseding the 2023 v3.2); the result-disclosure session; and the cascade-testing question for at-risk relatives.

Counselling models taught in the field include the non-directive tradition emphasised by Reed and his contemporaries; the Reciprocal-Engagement Model articulated by Veach, Bartels & LeRoy 2007 (J Genet Couns 16:713); and the broader shift toward shared-decision-making in genomic medicine. The diagnostics and counselling subtopic page covers each in detail, including the duty-to-warn discussion that sits at the boundary with the ELSI subtopic.

Subtopic 3: ethics, legal, and social issues

The ELSI Research Program of the US National Human Genome Research Institute was established in 1990 alongside the Human Genome Project, with a remit to anticipate and study the ethical, legal, and social consequences of human genetic and genomic research; the programme reserved up to 5% of the HGP budget for this work and remains the largest funder of bioethics research in the world (see genome.gov/elsi).

The contemporary ELSI conversation in genomics covers consent in a research and clinical setting; data protection (GDPR Article 9 special-category genetic data; the US Genetic Information Nondiscrimination Act 2008 and its limits); the duty-to-warn debate exemplified in the UK by ABC v St George's Healthcare NHS Trust (2020); regulation of direct-to-consumer testing (the FDA's 2013 warning letter to 23andMe); equity and the persistent under-representation of non-European ancestry in genomic data, surveyed in Sirugo, Williams & Tishkoff 2019 (Cell 177:26); and the limits of polygenic embryo selection as set out in Karavani et al. 2019 (Cell 179:1424) and Turley et al. 2021 (NEJM 385:78). The ELSI subtopic page covers each.

How this page connects to Evagene

Evagene is a research, education, and family-history-documentation tool. It is not a medical device, not clinical decision support, and is not used here as a recommendation engine. Where these teaching pages refer to pedigree drawing, the Evagene pages are useful as a reference for the notation and the practical mechanics: pedigree drawing tool, pedigree chart, how to draw a pedigree chart, NSGC pedigree notation, three-generation family history, and clinical pedigree drawing. Where the diagnostic and ELSI pages refer to risk models, the Evagene calculators (BRCAPRO, MMRpro, PancPRO, Lynch syndrome) are illustrative implementations of the published algorithms, intended for teaching and research; clinical-grade computation for BOADICEA, in particular, is run off-platform at canrisk.org after CanRisk file export from Evagene.

Reading order for trainees

The three subtopic pages can be read in any order, but the natural sequence for someone new to clinical genetics is:

Clinical genetic skills — the family-history interview, three-generation pedigree construction, the symbol set, ethnically and geographically informed history, and red-flag features described in published guidelines.
Diagnostics and counselling — molecular test ordering, ACMG/AMP variant classification, secondary findings, the disclosure conversation, the non-directive and Reciprocal-Engagement Model traditions, cascade testing, and reproductive-options education.
Ethics, legal, and social issues — ELSI as a research programme, GINA and GDPR, the duty-to-warn debate, forensic familial DNA searching, direct-to-consumer testing regulation, equity in genomics, newborn-screening expansion, and polygenic embryo selection.

For educators designing a module from these pages: each subtopic page cites between five and ten primary sources, and most are open-access or available through institutional access. The pages are deliberately descriptive rather than prescriptive; they describe what the literature says and how the field teaches itself, and avoid framing any of it as advice to the reader.

A boundary worth restating

None of the three subtopic pages, and not this pillar page, are intended to substitute for professional clinical-genetics training, supervision, or judgement. They are educational summaries of how the field is taught and discussed in the published literature. Nothing on these pages should be relied upon as medical advice; nothing here describes outputs from Evagene that are intended to diagnose, prevent, monitor, predict, treat, or manage disease. The pedigree drawing surface that Evagene provides is a documentation and teaching tool, not a clinical-pathway component.

Key sources cited

Reed, S. C. (1947). The local Dight Institute. J Hered 38(11). Coined "genetic counseling".
Sheldon, J. H. (1949). Studies in human inheritance, post-war establishment of human genetics clinics.
Resta et al. 2006. A new definition of genetic counseling. J Genet Couns 15:77.
Bennett et al. 2022. NSGC pedigree-standardization update. J Genet Couns 31:1238.
Bennett et al. 1995. Recommendations for standardised human pedigree nomenclature. J Genet Couns 4:267.
Bennett et al. 2008. Standardized human pedigree nomenclature: update and assessment. J Genet Couns 17:424.
Richards et al. 2015. Standards and guidelines for the interpretation of sequence variants (ACMG/AMP). Genet Med 17:405.
Sirugo, Williams & Tishkoff 2019. The missing diversity in human genetic studies. Cell 177:26.
NSGC. Founded 1979. www.nsgc.org.
NHGRI ELSI Research Program. genome.gov/elsi.

Clinical practice, ethics, and communication in genetics